Step Pharma Set To Leap Into Clinic With CTPS1 Inhibitor
French Biotech Raises €35m
After a fresh cash injection, Step is ready to take STP938 for the treatment of T-cell blood cancers into Phase I trials in February.
After a fresh cash injection, Step is ready to take STP938 for the treatment of T-cell blood cancers into Phase I trials in February.